Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1990 Apr;61(4):644. doi: 10.1038/bjc.1990.143

How nephrotoxic is carboplatin?

J R Hardy, S Tan, I Fryatt, E Wiltshaw
PMCID: PMC1971369  PMID: 2184881

Full text

PDF

Page 644

644

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chantler C., Garnett E. S., Parsons V., Veall N. Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci. 1969 Aug;37(1):169–180. [PubMed] [Google Scholar]
  2. Daugaard G., Rossing N., Rørth M. Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose. Cancer Chemother Pharmacol. 1988;21(2):163–167. doi: 10.1007/BF00257365. [DOI] [PubMed] [Google Scholar]
  3. Gore M. E., Calvert A. H., Smith L. E. High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1391–1397. doi: 10.1016/0277-5379(87)90125-8. [DOI] [PubMed] [Google Scholar]
  4. Sleijfer D. T., Smit E. F., Meijer S., Mulder N. H., Postmus P. E. Acute and cumulative effects of carboplatin on renal function. Br J Cancer. 1989 Jul;60(1):116–120. doi: 10.1038/bjc.1989.233. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES